BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 2370223)

  • 1. Plasma cortisol response to ketoconazole administration in dogs with hyperadrenocorticism.
    Feldman EC; Bruyette DS; Nelson RW; Farver TB
    J Am Vet Med Assoc; 1990 Jul; 197(1):71-8. PubMed ID: 2370223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of two low-dose dexamethasone suppression protocols as screening and discrimination tests in dogs with hyperadrenocorticism.
    Mack RE; Feldman EC
    J Am Vet Med Assoc; 1990 Dec; 197(12):1603-6. PubMed ID: 2177458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of mitotane treatment for adrenal tumor versus pituitary-dependent hyperadrenocorticism in dogs.
    Feldman EC; Nelson RW; Feldman MS; Farver TB
    J Am Vet Med Assoc; 1992 Jun; 200(11):1642-7. PubMed ID: 1320600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperadrenocorticism caused by bilateral adrenocortical neoplasia in dogs: four cases (1983-1988).
    Ford SL; Feldman EC; Nelson RW
    J Am Vet Med Assoc; 1993 Mar; 202(5):789-92. PubMed ID: 8454518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma cortisol response to exogenous ACTH in 22 dogs with hyperadrenocorticism caused by adrenocortical neoplasia.
    Peterson ME; Gilbertson SR; Drucker WD
    J Am Vet Med Assoc; 1982 Mar; 180(5):542-4. PubMed ID: 6277837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of ketoconazole to treat dogs with pituitary-dependent hyperadrenocorticism: 48 cases (1994-2007).
    Lien YH; Huang HP
    J Am Vet Med Assoc; 2008 Dec; 233(12):1896-901. PubMed ID: 19072605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of low- and high-dose dexamethasone tests for distinguishing pituitary-dependent from adrenal tumor hyperadrenocorticism in dogs.
    Feldman EC; Nelson RW; Feldman MS
    J Am Vet Med Assoc; 1996 Aug; 209(4):772-5. PubMed ID: 8756877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of the urine cortisol-to-creatinine ratio for monitoring dogs with pituitary-dependent hyperadrenocorticism during induction treatment with mitotane (o,p'-DDD).
    Randolph JF; Toomey J; Center SA; Scarlett JM; Reimers T; Graham P; Nachreiner RF
    Am J Vet Res; 1998 Mar; 59(3):258-61. PubMed ID: 9522940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a low-dose synthetic adrenocorticotropic hormone stimulation test in clinically normal dogs and dogs with naturally developing hyperadrenocorticism.
    Kerl ME; Peterson ME; Wallace MS; Melián C; Kemppainen RJ
    J Am Vet Med Assoc; 1999 May; 214(10):1497-501. PubMed ID: 10340075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results of surgical treatment for hyperadrenocorticism caused by adrenocortical neoplasia in the dog: 25 cases (1980-1984).
    Scavelli TD; Peterson ME; Matthiesen DT
    J Am Vet Med Assoc; 1986 Nov; 189(10):1360-4. PubMed ID: 3793588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-dexamethasone-suppressible, pituitary-dependent hyperadrenocorticism in a dog.
    Kemppainen RJ; Zenoble RD
    J Am Vet Med Assoc; 1985 Aug; 187(3):276-8. PubMed ID: 4030467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitotane treatment of 32 dogs with cortisol-secreting adrenocortical neoplasms.
    Kintzer PP; Peterson ME
    J Am Vet Med Assoc; 1994 Jul; 205(1):54-61. PubMed ID: 7928549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of disease on the results of diagnostic tests for use in detecting hyperadrenocorticism in dogs.
    Kaplan AJ; Peterson ME; Kemppainen RJ
    J Am Vet Med Assoc; 1995 Aug; 207(4):445-51. PubMed ID: 7591942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid metabolism in horses with hyperadrenocorticism.
    van der Kolk JH; Wensing T; Kalsbeek HC; Breukink HJ
    J Am Vet Med Assoc; 1995 Apr; 206(7):1010-2. PubMed ID: 7768707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Problems associated with medical therapy of canine hyperadrenocorticism.
    Nichols R
    Probl Vet Med; 1990 Dec; 2(4):551-6. PubMed ID: 2134073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the use of baseline cortisol concentration as a monitoring tool for dogs receiving trilostane as a treatment for hyperadrenocorticism.
    Cook AK; Bond KG
    J Am Vet Med Assoc; 2010 Oct; 237(7):801-5. PubMed ID: 20919845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of functional adrenocortical tumors on plasma cortisol and corticotropin concentrations in dogs.
    Feldman EC
    J Am Vet Med Assoc; 1981 Apr; 178(8):823-6. PubMed ID: 6268586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis of hyperadrenocorticism in dogs as compared to human diagnostic methods: a review.
    Thuróczy J; Balogh L; Huszenicza G; Jánoki GA; Kulcsár M
    Acta Vet Hung; 1998; 46(2):157-73. PubMed ID: 9704520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma free cortisol concentrations in dogs with hyperadrenocorticism.
    Kemppainen RJ; Peterson ME; Sartin JL
    Am J Vet Res; 1991 May; 52(5):682-6. PubMed ID: 1649561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ACTH-independent hyperadrenocorticism due to food-dependent hypercortisolemia in a dog: a case report.
    Galac S; Kars VJ; Voorhout G; Mol JA; Kooistra HS
    Vet J; 2008 Jul; 177(1):141-3. PubMed ID: 17572120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.